David is a healthcare and private equity professional who combines a deep scientific understanding with his investment expertise.
Having joined GHO in 2017, David currently works with the management team at FairJourney Biologics, having previously supported on GHO’s investment in Sterling Pharma Solutions.
David has over 6 years of clinical medicine experience across Australia and the United Kingdom, specialising in Anaesthetics and Trauma.
He holds an MBA with Distinction from London Business School, a Masters in Public Health from Australia’s Newcastle University and a Bachelor of Medicine and Surgery with Honours from Monash University, Australia. He is a native English speaker and is conversational in French.